Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies
Linda L. Bachinski(Baylor College of Medicine), Ralf Krahe(University of Helsinki), Valerie L. Neubauer(The University of Texas MD Anderson Cancer Center), Tetsuo Ashizawa(Cornell University), Jerry R. Mendell(Nationwide Children's Hospital), B. Eymard(University Hospital of Basel), Tamara J. Nixon(The University of Texas MD Anderson Cancer Center), Jiexin Zhang(The University of Texas MD Anderson Cancer Center), Bjarne Udd(Folkhälsans Forskningscentrum), Josep Gámez(Université Paris-Sud), Keith Baggerly(The University of Texas MD Anderson Cancer Center), Anna K. Unruh(The University of Texas MD Anderson Cancer Center), Lalitha Nagarajan(The University of Texas MD Anderson Cancer Center), Lubov Timchenko(Cincinnati Children's Hospital Medical Center), Guillaume Bassez(Centre Hospitalier Universitaire Henri-Mondor), Olayinka Raheem(Tampere University Hospital), Mario Sirito(Inserm)
Cited by 36
Related Papers
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in <i>NOTCH1</i>
|Science|2011|1.7k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k